Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

State-dependent responses to intracranial brain stimulation in a patient with depression

Nature Medicine volume 27, pages 229–231 (2021)Cite this article

Subjects

A Publisher Correction to this article was published on 08 August 2022

This article has been updated

Abstract

Deep brain stimulation is a promising treatment for severe depression, but lack of efficacy in randomized trials raises questions regarding anatomical targeting. We implanted multi-site intracranial electrodes in a severely depressed patient and systematically assessed the acute response to focal electrical neuromodulation. We found an elaborate repertoire of distinctive emotional responses that were rapid in onset, reproducible, and context and state dependent. Results provide proof of concept for personalized, circuit-specific medicine in psychiatry.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Mapping mood across the corticolimbic circuit.
Fig. 2: Characterization of response properties.

Similar content being viewed by others

Data availability

The source data that support the findings in this report are available in the report itself, in the Supplementary Information and in our publicly available code. Source data are provided with this paper.

Code availability

The code and data used to produce the figures in this paper are available at https://github.com/ScangosLab/PR01.

Change history

References

  1. Disease, G. B. D., Injury, I. & Prevalence, C. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392, 1789–1858 (2018).

    Article  Google Scholar 

  2. Howland, R. H. Sequenced treatment alternatives to relieve depression (STAR*D). Part 2: study outcomes. J. Psychosoc. Nurs. Ment. Health Serv. 46, 21–24 (2008).

    PubMed  Google Scholar 

  3. Mayberg, H. S. et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–660 (2005).

    Article  CAS  Google Scholar 

  4. Holtzheimer, P. E. et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry 4, 839–849 (2017).

    Article  Google Scholar 

  5. Dougherty, D. D. et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol. Psychiatry 78, 240–248 (2015).

    Article  Google Scholar 

  6. Bergfeld, I. O. et al. Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry 73, 456–464 (2016).

    Article  Google Scholar 

  7. Scangos, K. W. & Ross, D. A. What we’ve got here is failure to communicate: improving interventional psychiatry with closed-loop stimulation. Biol. Psychiatry 84, e55–e57 (2018).

    Article  Google Scholar 

  8. Mayberg, H. S., Riva-Posse, P. & Crowell, A. L. Deep brain stimulation for depression: keeping an eye on a moving target. JAMA Psychiatry 73, 439–440 (2016).

    Article  Google Scholar 

  9. Malone, D. A. Jr. et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol. Psychiatry 65, 267–275 (2009).

    Article  Google Scholar 

  10. Fraguas, D. et al. Mental disorders of known aetiology and precision medicine in psychiatry: a promising but neglected alliance. Psychol. Med. 47, 193–197 (2017).

    Article  CAS  Google Scholar 

  11. Riva-Posse, P. et al. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Mol. Psychiatry 23, 843–849 (2018).

    Article  CAS  Google Scholar 

  12. Choi, K. S., Riva-Posse, P., Gross, R. E. & Mayberg, H. S. Mapping the “depression switch” during intraoperative testing of subcallosal cingulate deep brain stimulation. JAMA Neurol. 72, 1252–1260 (2015).

    Article  Google Scholar 

  13. Tharin, S. & Golby, A. Functional brain mapping and its applications to neurosurgery. Neurosurgery 60, 185–201 (2007).

    PubMed  Google Scholar 

  14. Bishop, M. P., Elder, S. T. & Heath, R. G. Intracranial self-stimulation in man. Science 140, 394–396 (1963).

    Article  CAS  Google Scholar 

  15. Rao, V. R. et al. Direct electrical stimulation of lateral orbitofrontal cortex acutely improves mood in individuals with symptoms of depression. Curr. Biol. 28, 3893–3902 e3894 (2018).

    Article  CAS  Google Scholar 

  16. Kirkby, L. A. et al. An amygdala–hippocampus subnetwork that encodes variation in human mood. Cell 175, 1688–1700 (2018).

    Article  CAS  Google Scholar 

  17. Scangos, K. W. et al. Pilot study of an intracranial electroencephalography biomarker of depressive symptoms in epilepsy. J. Neuropsychiatry Clin. Neurosci. 32, 185–190 (2020).

    Article  Google Scholar 

  18. Timmerby, N., Andersen, J. H., Sondergaard, S., Ostergaard, S. D. & Bech, P. A systematic review of the clinimetric properties of the 6-item version of the Hamilton Depression Rating Scale (HAM-D6). Psychother. Psychosom. 86, 141–149 (2017).

    Article  CAS  Google Scholar 

  19. Inman, C. S. et al. Human amygdala stimulation effects on emotion physiology and emotional experience. Neuropsychologia 145, 106722 (2018).

    Article  Google Scholar 

  20. Machado, A. et al. Functional topography of the ventral striatum and anterior limb of the internal capsule determined by electrical stimulation of awake patients. Clin. Neurophysiol. 120, 1941–1948 (2009).

    Article  Google Scholar 

  21. Riva-Posse, P. et al. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 76, 963–969 (2014).

    Article  Google Scholar 

  22. Campbell, M. C. et al. Mood response to deep brain stimulation of the subthalamic nucleus in Parkinson’s disease. J. Neuropsychiatry Clin. Neurosci. 24, 28–36 (2012).

    Article  Google Scholar 

  23. Salloum, N. C. et al. Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression. Depress. Anxiety 36, 235–243 (2019).

    Article  CAS  Google Scholar 

  24. Mori, S. & van Zijl, P. C. Fiber tracking: principles and strategies—a technical review. NMR Biomed. 15, 468–480 (2002).

    Article  Google Scholar 

  25. Feffer, K. et al. 1Hz rTMS of the right orbitofrontal cortex for major depression: safety, tolerability and clinical outcomes. Eur. Neuropsychopharmacol. 28, 109–117 (2018).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institutes of Health award K23NS110962 (to K.W.S.), a NARSAD Young Investigator grant from the Brain and Behavioral Research Foundation (to K.W.S.) and the Ray and Dagmar Dolby Family Fund through the Department of Psychiatry at the University of California, San Francisco (to K.W.S., A.D.K., E.F.C. and L.P.S.). E.F.C. was supported by the National Institutes of Health (U01NS098971, R01MH114860, R01MH111444, R01DC015504, R01DC01237, UH3 NS109556, UH3NS115631 and R01 NS105675), the New York Stem Cell Foundation, the Howard Hughes Medical Institute, the McKnight Foundation, the Shurl and Kay Curci Foundation and the William K. Bowes Foundation. A.D.K. acknowledges support from the National Institutes of Health (P01AG019724, R01 HL142051-01, R01AG059794, R01DK117953, UH3 NS109556-01 and R01AG060477-01A1), PCORI, Janssen, Jazz, Axsome (AXS-05-301) and Reveal Biosensors. L.P.S. receives support from the National Institutes of Health (U24 DA041123).

Author information

Author notes

  1. These authors contributed equally: Edward F. Chang, Andrew D. Krystal.

Authors and Affiliations

  1. Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA

    Katherine W. Scangos, Ghassan S. Makhoul & Andrew D. Krystal

  2. Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA

    Leo P. Sugrue

  3. Department of Radiology, University of California, San Francisco, San Francisco, CA, USA

    Edward F. Chang

Authors
  1. Katherine W. Scangos
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Ghassan S. Makhoul
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Leo P. Sugrue
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Edward F. Chang
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Andrew D. Krystal
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

K.W.S., A.D.K. and E.F.C. initiated this work and supervised the study. K.W.S. drafted the manuscript, and G.S.M., K.W.S. and L.P.S. collected and analyzed the data. A.D.K. and E.G.C. finalized the manuscript. All authors approved this work and take responsibility for its integrity.

Corresponding author

Correspondence to Katherine W. Scangos.

Ethics declarations

Competing interests

A.D.K. consults for Eisai, Evecxia, Ferring, Galderma, Harmony Biosciences, Idorsia, Jazz, Janssen, Merck, Neurocrine, Pernix, Sage, Takeda, Big Health, Millenium Pharmaceuticals, Otsuka Pharmaceuticals, and Neurawell. All other authors declare no competing interests.

Additional information

Peer review information Jerome Staal and Kate Gao were the primary editors on this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Source data

Source Data Fig. 1

Statistical Source Data

Source Data Fig. 2

Statistical Source Data

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scangos, K.W., Makhoul, G.S., Sugrue, L.P. et al. State-dependent responses to intracranial brain stimulation in a patient with depression. Nat Med 27, 229–231 (2021). https://doi.org/10.1038/s41591-020-01175-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-020-01175-8

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing